250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 35 Medical Device VC Funds in Australia

A list of 35 VC funds that invest in Medical device startups based in Australia. We rank investors based on the number of investments they made in Medical device companies from Australia. We update this investor list every month.

Top 35 Medical Device VC Funds in Australia

Investor Medical Device Australia investments
Brandon Capital 7
Medical Research Commercialisation Fund (MRCF) 6
Artesian VC 5
Melbourne Angels 4
Global Health Investment Fund (GHIF) 2
Uniseed Ventures 2
Breakthrough Victoria 2
Regal Funds Management 2
CoAct Capital 1
Terra Rossa Capital 1
Significant Early Venture Capital 1
Blackbird Ventures 1
Sydney Angels 1
Grand Challenges Canada 1
OneVentures 1
BridgeLane Capital 1
Versant Ventures 1
CP Ventures 1
Transition Level Investments 1
Powerhouse Ventures 1
South Australian Venture Capital Fund 1
Victoria University of Wellington 1
Right Click Capital 1
Microsoft for Startups 1
HealthCare Ventures 1
VU Venture Partners 1
Ramsay Health Care 1
Horizons Ventures 1
Future of Healthcare Fund - Australian Unity 1
Skip Capital 1
Starfish Ventures 1
Playford Capital 1
Anova Capital 1
Fund WA 1
UniSA Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Brandon Capital VC Fund · Melbourne, Victoria, Australia · 2 investments in the past 12 months
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
  • Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
  • Pathios Therapeutics — Pioneering a novel macrophage conditioning approach to delivering breakthrough cancer therapies
Medical Research Commercialisation Fund (MRCF) VC Fund · Melbourne, Victoria, Australia
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Artesian VC VC Fund · Melbourne, Victoria, Australia · 7 investments in the past 12 months
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • Bygen — Bygen delivers high-quality activated carbon products while also facilitating large-scale, long-term carbon dioxide sequestration.
  • Sitemate — Sitemate builds user friendly software which thousands of industrial companies use every day to streamline their paperwork and processes.
  • Braingaze — Braingaze solves major challenges around cognitive disorders of the brain. We use a patented neuro-biomarker based on small involuntary eye movements. These are triggered by functional games, the resulting signal is analysed using algorithms trained by Deep Learning based on actual real patient / control cases. We adress pre-symptomatic stagesof Alzheimer's disease and the most common child cognitive disorder ADHD. Our tools are on the market and covered by a CE Mark as a medical device. Our pipeline includes detection / diagnostic tools as well as digital therapy solutions that have shown to reduce symtoms by over 50%.
Melbourne Angels VC Fund · Melbourne, Victoria, Australia
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
  • Alkira Software — Deliver interactive content and answer customer queries at scale using conversational AI. TalkVia offers quick and easy NO CODE voice and chat solutions for Amazon Alexa, Google Assistant, Siri and web based chatbots.
Global Health Investment Fund (GHIF) VC Fund · New York, New York, United States
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, India, Austria
Portfolio highlights
  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Uniseed Ventures VC Fund · Brisbane, Queensland, Australia
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro Breaks RecordWorld's Longest Wi-Fi HaLow Connection at 3 KilometersWatch Now Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah.
Breakthrough Victoria VC Fund · Melbourne, Victoria, Australia · 6 investments in the past 12 months
Independent company in Australia managing a $2 billion investment fund set up by the Victorian Government to make the state an innovation leader.
Show more
Investment focus
  • Software, Quantum Computing, Energy
  • Seed, Series A, Series B
  • Australia, Philippines, United States
Portfolio highlights
  • Bygen — Bygen delivers high-quality activated carbon products while also facilitating large-scale, long-term carbon dioxide sequestration.
  • Xefco — Xefco is a company that develops novel textile and coating technologies. It uses a global network of research partners to develop advanced manufacturing solutions and apply cutting-edge materials science, with an emphasis on functional enhancements, sustainable manufacturing, and decreased resource consumption.
  • Neo-Bionica — Neo-Bionica enables clients including businesses, researchers, and clinicians to turn their ideas into medical technologies that improve people’s lives. They specialize in the product realization of bioelectronic medical devices for use in targeted therapies and diagnostics.
Regal Funds Management VC Fund · Sydney, New South Wales, Australia
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Funding Round, Series B, Convertible Note
  • Australia, United States, United Kingdom
Portfolio highlights
  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
CoAct Capital VC Fund · Melbourne, Victoria, Australia
Co:Act is an investment partnership of experienced venture investors with a network of founders.
Show more
Investment focus
  • Advice, Hospital, Software
  • Series A, Funding Round
  • Australia
Portfolio highlights
  • Vantari VR — Virtual Reality for Healthcare
  • DASH Technology — DASH Technology provides financial services. They provide software, platform, and even wealth management space services. They provide advisers and broader wealth services. They provide inquiries through email, phone calls, and online applications.
Terra Rossa Capital VC Fund · Adelaide, South Australia, Australia
Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Australia
Portfolio highlights
  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Significant Early Venture Capital VC Fund · Canberra, Australian Capital Territory, Australia
Connecting innovation to the market.
Show more
Investment focus
  • Software, Information Technology, Electronics
  • Seed, Series A, Pre-Seed
  • Australia
Portfolio highlights
  • Vantari VR — Virtual Reality for Healthcare
  • FLAIM Systems — FLAIM Systems is a virtual reality platform that develops, produces and supports the next step in skills training for emergency services.
  • Liquid Instruments — Redefining the way scientists, engineers, students, and professionals experience test and measurement with Moku software-reconfigurable hardware platforms
Blackbird Ventures VC Fund · Sydney, New South Wales, Australia · 20 investments in the past 12 months
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Series A, Series B
  • Australia, United States, New Zealand
Portfolio highlights
  • Tracksuit — Tracksuit has created beautiful, always-on, and radically affordable brand tracking for modern consumer brands. Brand marketers and leaders at consumer brands have access to enterprise-tier brand tracking, specifically built for them, at a price point that works. Teams can easily track awareness, consideration, preference and brand associationsfrom real humans within the wider market, and compare results against competitors.
  • Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Sydney Angels VC Fund · Sydney, New South Wales, Australia
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
  • Software, SaaS, Apps
  • Seed, Funding Round, Angel
  • Australia, United States
Portfolio highlights
  • Remi AI — A.I-Powered Demand Forecasting, Supply Chain AI, & Price Optimisation | Remi AI
  • Trendspek — Trendspek's 3D software lets you manage high-value built assets faster, safer and with more accuracy. With millimetre detail, interact with exact digital replicas of infrastructure from your desk and collaborate with global stakeholders. Book a call with us to get started.
  • Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
Grand Challenges Canada VC Fund · Toronto, Ontario, Canada
Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health. They are funded by the Government of Canada and they fund innovators in low- and middle-income countries (LMICs) and Canada. The bold ideas they support integrate science and technology, social and business innovation – they call this IntegratedInnovation®. They focus on bringing successful innovation to scale, catalyzing sustainability and impact. They have a determined focus on results, and on saving and improving lives.Grand Challenges Canada works closely with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada to catalyze scale, sustainability and impact. Grand Challenges Canada takes an evidence-based approach to development innovation to save and improve lives in LMICs. They are a platform for development innovation in Maternal, Newborn and Child Health (MNCH) through their Saving Lives at Birth, Saving Brains and MNCH Stars in Global Health programs. They are also focused on helping the poorest and most vulnerable populations, for example those who suffer from mental illness.Since their launch in 2010, Grand Challenges Canada has supported a pipeline of over 700 projects in more than 80 countries. Their investments are producing results: Thousands of lives have been saved and over two hundred and eighty thousand lives have been improved, thus far. By 2030, these innovations have the potential to save hundreds of thousands of lives and improve millions of lives.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Grant, Seed, Debt Financing
  • Canada, United States, Australia
Portfolio highlights
  • OmniVis — OmniVis is a technology company creating handheld devices to rapidly detect dangerous pathogens - saving food and saving lives.
  • Nivi — Nivi is the best digital health chatbot built for whatsapp and rooted in behavioral science. Nivi enables users to take charge of their own health and works with private and public agencies to driver better public health outcomes.
  • Sensoreal — Sensoreal Inc. is a diagnostic device and service provider company. The company is developing a variety of biosensors, which can perform one-step immunoassays in low-cost, accurate and quantifiable manners. Sensoreal was founded in 2014, and is headquartered in Montreal, Canada.
OneVentures VC Fund · Sydney, New South Wales, Australia · 2 investments in the past 12 months
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Debt Financing, Funding Round
  • Australia, United States, Israel
Portfolio highlights
  • ImmVirX — ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
  • StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
  • Employment Hero — Employment Hero is Australia's top cloud-based HR, payroll and benefits platform for employers & employees. FREE trial for...
BridgeLane Capital VC Fund · Sydney, New South Wales, Australia
The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme
Show more
Investment focus
  • Software, Financial Services, Health Care
  • Seed, Series B, Funding Round
  • Australia, Germany
Portfolio highlights
  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Versant Ventures VC Fund · Menlo Park, California, United States · 7 investments in the past 12 months
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Switzerland, Canada
Portfolio highlights
  • Firefly Bio — Firefly specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
  • SixPeaks Bio — SixPeaks is developing a pipeline of medicines for healthy weight loss.
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
CP Ventures VC Fund · Sydney, New South Wales, Australia
CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Seed, Pre-Seed, Series A
  • Australia, United States, India
Portfolio highlights
  • Anility — Embed financial health insights within your application using our world leading API service
  • Ahura AI — Ahura AI, an EdTech startup using artificial intelligence to create personalized learning tools that replicate a 1-to-1 learning experience
  • Ensuredit — ENSUREDIT enables and empowers end customers and Insurance Intermediaries with AI-based product platforms for transformational customer experience.
Transition Level Investments VC Fund · Brisbane, Queensland, Australia
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more
Investment focus
  • SaaS, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • Australia, United States
Portfolio highlights
  • Kapiche — Top-rated customer feedback analytics platform. Instant insights. No setup or coding. Kapiche ingests & analyzes feedback in minutes for real customer insights.
  • FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
  • Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
Powerhouse Ventures VC Fund · Oakland, California, United States · 4 investments in the past 12 months
Powerhouse Ventures backs entrepreneurs building the digital infrastructure for rapid decarbonization.
Show more
Investment focus
  • Software, Energy, Solar
  • Seed, Series A, Pre-Seed
  • United States, Australia, United Kingdom
Portfolio highlights
  • SHAED — SHAED offers a mobility platform. It focuses on Shared, Hydrogen, Autonomous, Electric, and Distribution technologies. It speeds up the shift from traditional engines to electric and sustainable vehicles in the commercial sector.
  • Rock Rabbit — We make the rebate process quick, accurate, and efficient so contractors and homeowners can focus on their projects.
  • ThinkLabs AI — ThinkLabs AI is a specialist AI development and deployment firm. Its mission is to empower critical industries and infrastructure with trustworthy AI towards global energy sustainability.
South Australian Venture Capital Fund VC Fund · Adelaide, South Australia, Australia
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more
Investment focus
  • Health Care, Biotechnology, SaaS
  • Funding Round, Series A, Series B
  • Australia
Portfolio highlights
  • Lumary — Simplify Your Care Management Optimise Your Organisation Create Better Wellbeing
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Victoria University of Wellington VC Fund · Wellington, Wellington, New Zealand
A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Seed
  • Australia
Portfolio highlights
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Right Click Capital VC Fund · Sydney, New South Wales, Australia · 2 investments in the past 12 months
Right Click Capital - Australian Venture Capital Firm
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • Australia, Singapore, United States
Portfolio highlights
  • Cydarm — A case management platform that enables cybersecurity operations teams to collaborate, integrate, and respond with ease.
  • Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
  • Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Microsoft for Startups VC Fund · Redmond, Washington, United States · 4 investments in the past 12 months
Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Funding Round, Pre-Seed
  • United States, India, Canada
Portfolio highlights
  • VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
  • UniPay — UniPay is an eCommerce platform for infrastructure and industry-lacking regions that offers 5 products that enable trust, promote transparency, and enforce accountability.
  • Emission Sentri — Drive emission management and reduction with insights
HealthCare Ventures VC Fund · Cambridge, Massachusetts, United States
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, Australia, United Kingdom
Portfolio highlights
  • Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
  • Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
  • Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
VU Venture Partners VC Fund · San Francisco, California, United States · 5 investments in the past 12 months
A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech
Show more
Investment focus
  • Software, Health Care, Machine Learning
  • Seed, Funding Round, Series A
  • United States, Colombia, India
Portfolio highlights
  • Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
  • MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
  • Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Ramsay Health Care VC Fund · Sydney, New South Wales, Australia
Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A
  • Australia
Portfolio highlights
  • Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
Horizons Ventures VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 17 investments in the past 12 months
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Fano Labs — We are one of the leading AI companies specialising on Language AI technologies for enterprises in customer services, compliance and other lines of businesses.
  • Voyage Foods — Voyage Foods has made sustainable and scalable alternatives to foods that have current obstacles –environmental, social, and health alike. Our breakthrough technology provides endless opportunities to make delicious, nearly identical, versions of beloved foods, without compromising individual health or our planet. We replicated the world’s favoritefoods so that we can all enjoy them, forever.
  • Cauldron Ferm — Cauldron is sustainably delivering the precision fermented prototypes of today to the supermarket shelves of tomorrow.
Future of Healthcare Fund - Australian Unity VC Fund
A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians.
Show more
Investment focus
  • Health Care, Medical Device
  • Series A
  • Australia
Portfolio highlights
  • Baymatob — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
Skip Capital VC Fund · Sydney, New South Wales, Australia
Skip Capital is a private investment fund investing in technology and infrastructure
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Series A, Seed, Series B
  • Australia, Canada, United States
Portfolio highlights
  • Neara — Neara electric utility software is a physics-enabled platform that builds 3D interactive models of critical infrastructure networks and assets. Request a demo.
  • Human — Human aims to assist medical professionals and patients to make more statistics selections.
  • Morse Micro — Morse Micro Breaks RecordWorld's Longest Wi-Fi HaLow Connection at 3 KilometersWatch Now Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah.
Starfish Ventures VC Fund · Melbourne, Victoria, Australia
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
  • Software, Enterprise Software, Information Technology
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines
Portfolio highlights
  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,209,756 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Playford Capital VC Fund · Adelaide, South Australia, Australia
Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Australia
Portfolio highlights
  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Anova Capital VC Fund · Beijing, Beijing, China
Anova Capital focus on investment in education, big health and new consumption.
Show more
Investment focus
  • Education, Rental, Travel
  • Series A, Seed
  • China, Australia
Portfolio highlights
  • Qukoucai — Qukoucai is an online interactive learning platform for children and children. It focuses on providing customized online personal eloquence courses for 4-12 years old children. It includes a complete closed-loop product of teaching, practice, evaluation and display, and is committed to improving children's eloquence. ability.
  • Vantari VR — Virtual Reality for Healthcare
  • Woody Library — Woody Library is the first subscription-based book sharing and rental platform in China. In the cabin, you can spend the least amount of money, read the most books, and never again, the book that bought the hand has turned over a few pages and found that it has no long-term collection value.
Fund WA VC Fund · Perth, Western Australia, Australia · 3 investments in the past 12 months
We invest in Western Australian Innovators with bold ideas and global ambitions. We invest at Seed to Series-A in Western Australian companies.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Seed, Series A
  • Australia
Portfolio highlights
  • Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
  • VitalTrace — VitalTrace is a medical device company helps mothers and children during labour and delivery by innovating new monitoring devices.
UniSA Ventures VC Fund
UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed
  • Australia
Portfolio highlights
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Framework — All-in-one productivity tool for teams & individuals.
Investors by industry
Investors by country
VC Funds in Australia by industry